Tuberculosis Verrucosa Cutis Presenting as an Annular Hyperkeratotic Plaque

Tuberculosis verrucosa cutis (TVC) is a form of cutaneous tuberculosis that results from accidental inoculation of Mycobacterium tuberculosis in a previously infected or sensitized individual with a moderate to high degree of slowly evolving cell-mediated immunity. TVC usually begins as a solitary papulonodule following a trivial injury or trauma on one of the extremities that soon acquires a scaly and verrucous surface. The lesion, which is usually persistent, expands slowly over several months or years with or without central clearing and atrophy. We report a case of TVC in a 15-year-old girl that was undiagnosed for 10 years. The diagnosis was confirmed by a positive mycobacterial culture and characteristic histopathologic findings of the biopsy specimens. The patient responded well to antituberculous therapy (ATT), and the lesion resolved with residual scarring.

Case Report
A 15-year-old girl presented with a 10-year history of a slowly enlarging asymptomatic warty plaque over the right knee. The lesion started as a small asymptomatic red papule following a trivial injury and slowly progressed over several months to form a large warty plaque covered with a thick scale. The patient and her mother reported that the lesion also would get tender, intermittently discharging yellowish exudate. The lesion initially was treated with home remedies and later with topical steroids and oral antibiotics prescribed by local physicians, but the lesion continued expanding slowly to involve a large area of the right knee and upper leg. There was neither a family history of nor any known contacts with tuberculosis. Results of a physical examination revealed a 4X7-cm, large, well-defined, verrucous, thick, scaly, linear plaque situated over the right knee with involvement of the lower aspect of the anterior thigh and the right anterior upper aspect of the leg. Central clearing with atrophy gave the lesion a somewhat annular shape (Figure 1). Diascopy results did not show an apple jelly—brown color. Regional lymph nodes were not palpable.

The remainder of the physical examination showed unremarkable findings. A bacillus Calmette-Guérin vaccination scar could be identified on the left deltoid. Routine blood and urinalyses results were within reference range. Purified protein derivative test results were strongly positive (>15 mm of induration after 72 hours). Findings from a chest x-ray revealed no evidence of pulmonary disease. Histopathologic examination results of a biopsy specimen taken from the lesion revealed marked epidermal hyperkeratosis, acanthosis, pseudoepitheliomatous hyperplasia, and multiple well-formed tuberculous granulomas in the dermis (Figure 2). Each of the granulomas consisted of large numbers of lymphocytes, neutrophils, histiocytes, and Langhans giant cells (Figure 3). However, caseation necrosis was not present, and acid-fast bacilli could not be found. Mycobacterium tuberculosis was cultured from the biopsy specimen.

Daily oral antituberculous therapy (ATT) (rifampicin 450 mg/d, isoniazid 300 mg, and pyrazinamide 1200 mg) was recommended for 3 months (Figure 4). The patient responded well to the treatment and there was perceptible regression of the skin lesion. Treatment was continued with rifampicin 450 mg/d and isoniazid 300 mg/d for another 6 months, resulting in complete regression of the lesion with residual scarring.

Comment
Tuberculosis is a serious public health concern in developing countries due to lower socioeconomic status, malnutrition, and overcrowding; additionally, the morbidity and mortality rates of the disease are increasing rapidly in these countries. The incidence of tuberculosis also is on the rise in developed countries, including the United States and United Kingdom, both of which were previously considered free of this disease.1,2 Systemic tuberculosis was well-documented in ancient medical scriptures, but its first intelligent description, phthisis (to waste away), was given by Hippocrates (circa 460—376 BC).3 Cutaneous tuberculosis makes up only a small proportion of the cases of extrapulmonary tuberculosis. Children and immunocompromised adults are at increased risk of developing this form of the disease.3 Cutaneous tuberculosis may present in a number of diverse clinical forms (Table). The 4 major categories of cutaneous tuberculosis that have been described in the literature include: (1) inoculation from an exogenous source (ie, tuberculous chancre, tuberculosis verrucosa cutis [TVC]); (2) endogenous cutaneous spread either contiguous or by autoinoculation (ie, tuberculosis cutis orificialis, scrofuloderma); (3) hematogenous spread (ie, lupus vulgaris, acute miliary tuberculosis, tuberculosis ulcer/gumma/abscess); and (4) tuberculids (ie, erythema induratum [Bazin disease], papulonecrotic tuberculids, lichen scrofulosorum).4,5

TVC is a form of cutaneous tuberculosis that results from accidental inoculation of M tuberculosis into the skin through open wounds or abrasions in previously infected or sensitized individuals with a moderate to high degree of immunity,6 as opposed to tuberculosis chancre, which occurs in uninfected or unsensitized individuals. Individuals vaccinated with the bacillus Calmette-Guérin vaccine have been sensitized and carry a higher risk of developing TVC.7 In low socioeconomic environments, children can be infected by playing on ground contaminated with tuberculous sputum.8 Autoinoculation of a wound with a patient's own tuberculous sputum rarely causes TVC.7 The sites of predilection for inoculation tuberculosis in children are the lower extremities (ie, knees, thighs, and buttocks) because these areas are most likely to be traumatized. In adults, fingers and hands frequently are involved. The historically well-known "prosector's wart" is considered a prototype of TVC and is caused by accidental inoculation during autopsy.4 The diagnosis of TVC should be based on history and evolution of the disease, cardinal morphologic features, histopathologic characteristics, and mycobacterial culture of the biopsy specimen. The lesions of TVC typically are asymptomatic and start as small papules that slowly progress to verrucous or hyperkeratotic plaques over several months to years.9 Superficial scaling and fissuring with subsequent intermittent purulent discharge may occur. There may be central clearing with scarring and atrophy, as seen in this case. The disease usually runs a prolonged course with persistent verrucous lesions, especially if left untreated.9 Regional lymph nodes commonly are not enlarged unless there is superadded bacterial infection.10 Other organs, including the lungs, bone, and kidneys, do not appear to be affected in TVC, which differs from other forms of cutaneous tuberculosis.11 TVC is only locally invasive and usually does not cause any deformity or functional impairment of the affected extremity, but exceptions can occur.9 Differentiation from infection with atypical mycobacteria may prove to be difficult and usually requires culture of the causative organism.4,12 Other unusual infections such as North American blastomycosis, chromoblastomycosis, Majocchi granuloma, and fixed sporotrichosis may need to be differentiated from TVC by histopathology. Inflammatory dermatoses, including psoriasis, lichen simplex chronicus, hypertrophic discoid lupus erythematosus, and hypertrophic lichen planus, also may mimic TVC but are differentiated on the basis of characteristic clinical findings and histopathology.4,12 The histopathologic features of TVC include a pseudoepitheliomatous epidermal hyperplasia with hyperkeratosis and a dense dermal infiltrate of neutrophils, lymphocytes, and giant cells arranged in multiple well-formed tuberculous granulomas.13,14 Acid-fast bacilli rarely are seen and typical tuberculous foci with caseation necrosis are uncommon. Case reports in the literature indicate the usefulness of polymerase chain reaction for the detection of M tuberculosis in cutaneous tuberculosis.13,14 Polymerase chain reaction has not been found to be very helpful in the paucibacillary forms of cutaneous tuberculosis such as TVC.14 In cases for which the clinician has strong suspicion but negative laboratory test results, it might be possible to use the dramatic response to ATT as a diagnostic criterion.15,16 A study of patients with equivocal laboratory results noted 100% clinical improvement in all patients taking ATT for 20 days, and it has been proposed that response to treatment in 4 weeks can be used to support the diagnosis.11 Standard multidrug ATT is the treatment of choice and most lesions resolve after 4 to 5 months.17 An intensive phase of ATT consists of rifampicin, isoniazid, and pyrazinamide used for 2 months, with rifampicin and isoniazid continued for an additional 4 to 10 months. In cases of isoniazid resistance, ethambutol may be added to the regimen.15 The intensive-phase treatment should result in perceptible regression of the lesion, prompting the treating physician to continue the treatment through the continuation phase. Surgical excision of the isolated lesion also is useful.4 Our case of cutaneous tuberculosis remained undiagnosed for an unusually long period of 10 years. Although cutaneous tuberculosis may be regarded as a rare finding in the United States and other developed countries, it is not uncommon in countries with endemic tuberculosis. Delay in referral may lead to long-standing extensive lesions, as in this case. Physician awareness and education of early diagnosis and management of cutaneous tuberculosis are key to reducing the number of cases similar to ours. Acknowledgment—The authors wish to thank Elizabeth Davis, MFA, at the Wellman Center for Photomedicine, Boston, Massachusetts, for her editorial assistance.

Tuberculosis verrucosa cutis (TVC) is a form of cutaneous tuberculosis that results from accidental inoculation of Mycobacterium tuberculosis in a previously infected or sensitized individual with a moderate to high degree of slowly evolving cell-mediated immunity. TVC usually begins as a solitary papulonodule following a trivial injury or trauma on one of the extremities that soon acquires a scaly and verrucous surface. The lesion, which is usually persistent, expands slowly over several months or years with or without central clearing and atrophy. We report a case of TVC in a 15-year-old girl that was undiagnosed for 10 years. The diagnosis was confirmed by a positive mycobacterial culture and characteristic histopathologic findings of the biopsy specimens. The patient responded well to antituberculous therapy (ATT), and the lesion resolved with residual scarring.

Case Report
A 15-year-old girl presented with a 10-year history of a slowly enlarging asymptomatic warty plaque over the right knee. The lesion started as a small asymptomatic red papule following a trivial injury and slowly progressed over several months to form a large warty plaque covered with a thick scale. The patient and her mother reported that the lesion also would get tender, intermittently discharging yellowish exudate. The lesion initially was treated with home remedies and later with topical steroids and oral antibiotics prescribed by local physicians, but the lesion continued expanding slowly to involve a large area of the right knee and upper leg. There was neither a family history of nor any known contacts with tuberculosis. Results of a physical examination revealed a 4X7-cm, large, well-defined, verrucous, thick, scaly, linear plaque situated over the right knee with involvement of the lower aspect of the anterior thigh and the right anterior upper aspect of the leg. Central clearing with atrophy gave the lesion a somewhat annular shape (Figure 1). Diascopy results did not show an apple jelly—brown color. Regional lymph nodes were not palpable.

The remainder of the physical examination showed unremarkable findings. A bacillus Calmette-Guérin vaccination scar could be identified on the left deltoid. Routine blood and urinalyses results were within reference range. Purified protein derivative test results were strongly positive (>15 mm of induration after 72 hours). Findings from a chest x-ray revealed no evidence of pulmonary disease. Histopathologic examination results of a biopsy specimen taken from the lesion revealed marked epidermal hyperkeratosis, acanthosis, pseudoepitheliomatous hyperplasia, and multiple well-formed tuberculous granulomas in the dermis (Figure 2). Each of the granulomas consisted of large numbers of lymphocytes, neutrophils, histiocytes, and Langhans giant cells (Figure 3). However, caseation necrosis was not present, and acid-fast bacilli could not be found. Mycobacterium tuberculosis was cultured from the biopsy specimen.

Daily oral antituberculous therapy (ATT) (rifampicin 450 mg/d, isoniazid 300 mg, and pyrazinamide 1200 mg) was recommended for 3 months (Figure 4). The patient responded well to the treatment and there was perceptible regression of the skin lesion. Treatment was continued with rifampicin 450 mg/d and isoniazid 300 mg/d for another 6 months, resulting in complete regression of the lesion with residual scarring.

Comment
Tuberculosis is a serious public health concern in developing countries due to lower socioeconomic status, malnutrition, and overcrowding; additionally, the morbidity and mortality rates of the disease are increasing rapidly in these countries. The incidence of tuberculosis also is on the rise in developed countries, including the United States and United Kingdom, both of which were previously considered free of this disease.1,2 Systemic tuberculosis was well-documented in ancient medical scriptures, but its first intelligent description, phthisis (to waste away), was given by Hippocrates (circa 460—376 BC).3 Cutaneous tuberculosis makes up only a small proportion of the cases of extrapulmonary tuberculosis. Children and immunocompromised adults are at increased risk of developing this form of the disease.3 Cutaneous tuberculosis may present in a number of diverse clinical forms (Table). The 4 major categories of cutaneous tuberculosis that have been described in the literature include: (1) inoculation from an exogenous source (ie, tuberculous chancre, tuberculosis verrucosa cutis [TVC]); (2) endogenous cutaneous spread either contiguous or by autoinoculation (ie, tuberculosis cutis orificialis, scrofuloderma); (3) hematogenous spread (ie, lupus vulgaris, acute miliary tuberculosis, tuberculosis ulcer/gumma/abscess); and (4) tuberculids (ie, erythema induratum [Bazin disease], papulonecrotic tuberculids, lichen scrofulosorum).4,5

TVC is a form of cutaneous tuberculosis that results from accidental inoculation of M tuberculosis into the skin through open wounds or abrasions in previously infected or sensitized individuals with a moderate to high degree of immunity,6 as opposed to tuberculosis chancre, which occurs in uninfected or unsensitized individuals. Individuals vaccinated with the bacillus Calmette-Guérin vaccine have been sensitized and carry a higher risk of developing TVC.7 In low socioeconomic environments, children can be infected by playing on ground contaminated with tuberculous sputum.8 Autoinoculation of a wound with a patient's own tuberculous sputum rarely causes TVC.7 The sites of predilection for inoculation tuberculosis in children are the lower extremities (ie, knees, thighs, and buttocks) because these areas are most likely to be traumatized. In adults, fingers and hands frequently are involved. The historically well-known "prosector's wart" is considered a prototype of TVC and is caused by accidental inoculation during autopsy.4 The diagnosis of TVC should be based on history and evolution of the disease, cardinal morphologic features, histopathologic characteristics, and mycobacterial culture of the biopsy specimen. The lesions of TVC typically are asymptomatic and start as small papules that slowly progress to verrucous or hyperkeratotic plaques over several months to years.9 Superficial scaling and fissuring with subsequent intermittent purulent discharge may occur. There may be central clearing with scarring and atrophy, as seen in this case. The disease usually runs a prolonged course with persistent verrucous lesions, especially if left untreated.9 Regional lymph nodes commonly are not enlarged unless there is superadded bacterial infection.10 Other organs, including the lungs, bone, and kidneys, do not appear to be affected in TVC, which differs from other forms of cutaneous tuberculosis.11 TVC is only locally invasive and usually does not cause any deformity or functional impairment of the affected extremity, but exceptions can occur.9 Differentiation from infection with atypical mycobacteria may prove to be difficult and usually requires culture of the causative organism.4,12 Other unusual infections such as North American blastomycosis, chromoblastomycosis, Majocchi granuloma, and fixed sporotrichosis may need to be differentiated from TVC by histopathology. Inflammatory dermatoses, including psoriasis, lichen simplex chronicus, hypertrophic discoid lupus erythematosus, and hypertrophic lichen planus, also may mimic TVC but are differentiated on the basis of characteristic clinical findings and histopathology.4,12 The histopathologic features of TVC include a pseudoepitheliomatous epidermal hyperplasia with hyperkeratosis and a dense dermal infiltrate of neutrophils, lymphocytes, and giant cells arranged in multiple well-formed tuberculous granulomas.13,14 Acid-fast bacilli rarely are seen and typical tuberculous foci with caseation necrosis are uncommon. Case reports in the literature indicate the usefulness of polymerase chain reaction for the detection of M tuberculosis in cutaneous tuberculosis.13,14 Polymerase chain reaction has not been found to be very helpful in the paucibacillary forms of cutaneous tuberculosis such as TVC.14 In cases for which the clinician has strong suspicion but negative laboratory test results, it might be possible to use the dramatic response to ATT as a diagnostic criterion.15,16 A study of patients with equivocal laboratory results noted 100% clinical improvement in all patients taking ATT for 20 days, and it has been proposed that response to treatment in 4 weeks can be used to support the diagnosis.11 Standard multidrug ATT is the treatment of choice and most lesions resolve after 4 to 5 months.17 An intensive phase of ATT consists of rifampicin, isoniazid, and pyrazinamide used for 2 months, with rifampicin and isoniazid continued for an additional 4 to 10 months. In cases of isoniazid resistance, ethambutol may be added to the regimen.15 The intensive-phase treatment should result in perceptible regression of the lesion, prompting the treating physician to continue the treatment through the continuation phase. Surgical excision of the isolated lesion also is useful.4 Our case of cutaneous tuberculosis remained undiagnosed for an unusually long period of 10 years. Although cutaneous tuberculosis may be regarded as a rare finding in the United States and other developed countries, it is not uncommon in countries with endemic tuberculosis. Delay in referral may lead to long-standing extensive lesions, as in this case. Physician awareness and education of early diagnosis and management of cutaneous tuberculosis are key to reducing the number of cases similar to ours. Acknowledgment—The authors wish to thank Elizabeth Davis, MFA, at the Wellman Center for Photomedicine, Boston, Massachusetts, for her editorial assistance.

Tuberculosis verrucosa cutis (TVC) is a form of cutaneous tuberculosis that results from accidental inoculation of Mycobacterium tuberculosis in a previously infected or sensitized individual with a moderate to high degree of slowly evolving cell-mediated immunity. TVC usually begins as a solitary papulonodule following a trivial injury or trauma on one of the extremities that soon acquires a scaly and verrucous surface. The lesion, which is usually persistent, expands slowly over several months or years with or without central clearing and atrophy. We report a case of TVC in a 15-year-old girl that was undiagnosed for 10 years. The diagnosis was confirmed by a positive mycobacterial culture and characteristic histopathologic findings of the biopsy specimens. The patient responded well to antituberculous therapy (ATT), and the lesion resolved with residual scarring.

Case Report
A 15-year-old girl presented with a 10-year history of a slowly enlarging asymptomatic warty plaque over the right knee. The lesion started as a small asymptomatic red papule following a trivial injury and slowly progressed over several months to form a large warty plaque covered with a thick scale. The patient and her mother reported that the lesion also would get tender, intermittently discharging yellowish exudate. The lesion initially was treated with home remedies and later with topical steroids and oral antibiotics prescribed by local physicians, but the lesion continued expanding slowly to involve a large area of the right knee and upper leg. There was neither a family history of nor any known contacts with tuberculosis. Results of a physical examination revealed a 4X7-cm, large, well-defined, verrucous, thick, scaly, linear plaque situated over the right knee with involvement of the lower aspect of the anterior thigh and the right anterior upper aspect of the leg. Central clearing with atrophy gave the lesion a somewhat annular shape (Figure 1). Diascopy results did not show an apple jelly—brown color. Regional lymph nodes were not palpable.

The remainder of the physical examination showed unremarkable findings. A bacillus Calmette-Guérin vaccination scar could be identified on the left deltoid. Routine blood and urinalyses results were within reference range. Purified protein derivative test results were strongly positive (>15 mm of induration after 72 hours). Findings from a chest x-ray revealed no evidence of pulmonary disease. Histopathologic examination results of a biopsy specimen taken from the lesion revealed marked epidermal hyperkeratosis, acanthosis, pseudoepitheliomatous hyperplasia, and multiple well-formed tuberculous granulomas in the dermis (Figure 2). Each of the granulomas consisted of large numbers of lymphocytes, neutrophils, histiocytes, and Langhans giant cells (Figure 3). However, caseation necrosis was not present, and acid-fast bacilli could not be found. Mycobacterium tuberculosis was cultured from the biopsy specimen.

Daily oral antituberculous therapy (ATT) (rifampicin 450 mg/d, isoniazid 300 mg, and pyrazinamide 1200 mg) was recommended for 3 months (Figure 4). The patient responded well to the treatment and there was perceptible regression of the skin lesion. Treatment was continued with rifampicin 450 mg/d and isoniazid 300 mg/d for another 6 months, resulting in complete regression of the lesion with residual scarring.

Comment
Tuberculosis is a serious public health concern in developing countries due to lower socioeconomic status, malnutrition, and overcrowding; additionally, the morbidity and mortality rates of the disease are increasing rapidly in these countries. The incidence of tuberculosis also is on the rise in developed countries, including the United States and United Kingdom, both of which were previously considered free of this disease.1,2 Systemic tuberculosis was well-documented in ancient medical scriptures, but its first intelligent description, phthisis (to waste away), was given by Hippocrates (circa 460—376 BC).3 Cutaneous tuberculosis makes up only a small proportion of the cases of extrapulmonary tuberculosis. Children and immunocompromised adults are at increased risk of developing this form of the disease.3 Cutaneous tuberculosis may present in a number of diverse clinical forms (Table). The 4 major categories of cutaneous tuberculosis that have been described in the literature include: (1) inoculation from an exogenous source (ie, tuberculous chancre, tuberculosis verrucosa cutis [TVC]); (2) endogenous cutaneous spread either contiguous or by autoinoculation (ie, tuberculosis cutis orificialis, scrofuloderma); (3) hematogenous spread (ie, lupus vulgaris, acute miliary tuberculosis, tuberculosis ulcer/gumma/abscess); and (4) tuberculids (ie, erythema induratum [Bazin disease], papulonecrotic tuberculids, lichen scrofulosorum).4,5

TVC is a form of cutaneous tuberculosis that results from accidental inoculation of M tuberculosis into the skin through open wounds or abrasions in previously infected or sensitized individuals with a moderate to high degree of immunity,6 as opposed to tuberculosis chancre, which occurs in uninfected or unsensitized individuals. Individuals vaccinated with the bacillus Calmette-Guérin vaccine have been sensitized and carry a higher risk of developing TVC.7 In low socioeconomic environments, children can be infected by playing on ground contaminated with tuberculous sputum.8 Autoinoculation of a wound with a patient's own tuberculous sputum rarely causes TVC.7 The sites of predilection for inoculation tuberculosis in children are the lower extremities (ie, knees, thighs, and buttocks) because these areas are most likely to be traumatized. In adults, fingers and hands frequently are involved. The historically well-known "prosector's wart" is considered a prototype of TVC and is caused by accidental inoculation during autopsy.4 The diagnosis of TVC should be based on history and evolution of the disease, cardinal morphologic features, histopathologic characteristics, and mycobacterial culture of the biopsy specimen. The lesions of TVC typically are asymptomatic and start as small papules that slowly progress to verrucous or hyperkeratotic plaques over several months to years.9 Superficial scaling and fissuring with subsequent intermittent purulent discharge may occur. There may be central clearing with scarring and atrophy, as seen in this case. The disease usually runs a prolonged course with persistent verrucous lesions, especially if left untreated.9 Regional lymph nodes commonly are not enlarged unless there is superadded bacterial infection.10 Other organs, including the lungs, bone, and kidneys, do not appear to be affected in TVC, which differs from other forms of cutaneous tuberculosis.11 TVC is only locally invasive and usually does not cause any deformity or functional impairment of the affected extremity, but exceptions can occur.9 Differentiation from infection with atypical mycobacteria may prove to be difficult and usually requires culture of the causative organism.4,12 Other unusual infections such as North American blastomycosis, chromoblastomycosis, Majocchi granuloma, and fixed sporotrichosis may need to be differentiated from TVC by histopathology. Inflammatory dermatoses, including psoriasis, lichen simplex chronicus, hypertrophic discoid lupus erythematosus, and hypertrophic lichen planus, also may mimic TVC but are differentiated on the basis of characteristic clinical findings and histopathology.4,12 The histopathologic features of TVC include a pseudoepitheliomatous epidermal hyperplasia with hyperkeratosis and a dense dermal infiltrate of neutrophils, lymphocytes, and giant cells arranged in multiple well-formed tuberculous granulomas.13,14 Acid-fast bacilli rarely are seen and typical tuberculous foci with caseation necrosis are uncommon. Case reports in the literature indicate the usefulness of polymerase chain reaction for the detection of M tuberculosis in cutaneous tuberculosis.13,14 Polymerase chain reaction has not been found to be very helpful in the paucibacillary forms of cutaneous tuberculosis such as TVC.14 In cases for which the clinician has strong suspicion but negative laboratory test results, it might be possible to use the dramatic response to ATT as a diagnostic criterion.15,16 A study of patients with equivocal laboratory results noted 100% clinical improvement in all patients taking ATT for 20 days, and it has been proposed that response to treatment in 4 weeks can be used to support the diagnosis.11 Standard multidrug ATT is the treatment of choice and most lesions resolve after 4 to 5 months.17 An intensive phase of ATT consists of rifampicin, isoniazid, and pyrazinamide used for 2 months, with rifampicin and isoniazid continued for an additional 4 to 10 months. In cases of isoniazid resistance, ethambutol may be added to the regimen.15 The intensive-phase treatment should result in perceptible regression of the lesion, prompting the treating physician to continue the treatment through the continuation phase. Surgical excision of the isolated lesion also is useful.4 Our case of cutaneous tuberculosis remained undiagnosed for an unusually long period of 10 years. Although cutaneous tuberculosis may be regarded as a rare finding in the United States and other developed countries, it is not uncommon in countries with endemic tuberculosis. Delay in referral may lead to long-standing extensive lesions, as in this case. Physician awareness and education of early diagnosis and management of cutaneous tuberculosis are key to reducing the number of cases similar to ours. Acknowledgment—The authors wish to thank Elizabeth Davis, MFA, at the Wellman Center for Photomedicine, Boston, Massachusetts, for her editorial assistance.